Alpha-2B adrenergic receptor
Details
- Name
- Alpha-2B adrenergic receptor
- Synonyms
- ADRA2L1
- ADRA2RL1
- Alpha-2 adrenergic receptor subtype C2
- Alpha-2B adrenoceptor
- Alpha-2B adrenoreceptor
- Alpha-2BAR
- Gene Name
- ADRA2B
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0010396|Alpha-2B adrenergic receptor MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADIL VATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEY NSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGS FFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASV ASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEE EEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRRAQL TREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSSLNP VIYTIFNQDFRRAFRRILCRPWTQTAW
- Number of residues
- 447
- Molecular Weight
- 49565.8
- Theoretical pI
- 8.52
- GO Classification
- Functionsalpha2-adrenergic receptor activity / epinephrine bindingProcessesactivation of MAPK activity by adrenergic receptor signaling pathway / activation of protein kinase B activity / blood coagulation / cell-cell signaling / epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway / G-protein coupled receptor signaling pathway / negative regulation of epinephrine secretion / negative regulation of norepinephrine secretion / platelet activation / positive regulation of neuron differentiation / regulation of smooth muscle contraction / regulation of vasoconstrictionComponentsintegral component of plasma membrane / plasma membrane
- General Function
- Epinephrine binding
- Specific Function
- Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine > norepinephrine > epinephrine = oxymetazoline > dopamine > p-tyramine = phenylephrine > serotonin > p-synephrine / p-octopamine. For antagonists, the rank order is yohimbine > chlorpromazine > phentolamine > mianserine > spiperone > prazosin > alprenolol > propanolol > pindolol.
- Pfam Domain Function
- 7tm_1 (PF00001)
- Transmembrane Regions
- 13-38 49-69 87-107 129-149 173-193 370-393 403-423
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0010397|Alpha-2B adrenergic receptor (ADRA2B) ATGGACCACCAGGACCCCTACTCCGTGCAGGCCACAGCGGCCATAGCGGCGGCCATCACC TTCCTCATTCTCTTTACCATCTTCGGCAACGCTCTGGTCATCCTGGCTGTGTTGACCAGC CGCTCGCTGCGCGCCCCTCAGAACCTGTTCCTGGTGTCGCTGGCCGCCGCCGACATCCTG GTGGCCACGCTCATCATCCCTTTCTCGCTGGCCAACGAGCTGCTGGGCTACTGGTACTTC CGGCGCACGTGGTGCGAGGTGTACCTGGCGCTCGACGTGCTCTTCTGCACCTCGTCCATC GTGCACCTGTGCGCCATCAGCCTGGACCGCTACTGGGCCGTGAGCCGCGCGCTGGAGTAC AACTCCAAGCGCACCCCGCGCCGCATCAAGTGCATCATCCTCACTGTGTGGCTCATCGCC GCCGTCATCTCGCTGCCGCCCCTCATCTACAAGGGCGACCAGGGCCCCCAGCCGCGCGGG CGCCCCCAGTGCAAGCTCAACCAGGAGGCCTGGTACATCCTGGCCTCCAGCATCGGATCT TTCTTTGCTCCTTGCCTCATCATGATCCTTGTCTACCTGCGCATCTACCTGATCGCCAAA CGCAGCAACCGCAGAGGTCCCAGGGCCAAGGGGGGGCCTGGGCAGGGTGAGTCCAAGCAG CCCCGACCCGACCATGGTGGGGCTTTGGCCTCAGCCAAACTGCCAGCCCTGGCCTCTGTG GCTTCTGCCAGAGAGGTCAACGGACACTCGAAGTCCACTGGGGAGAAGGAGGAGGGGGAG ACCCCTGAAGATACTGGGACCCGGGCCTTGCCACCCAGTTGGGCTGCCCTTCCCAACTCA GGCCAGGGCCAGAAGGAGGGTGTTTGTGGGGCATCTCCAGAGGATGAAGCTGAAGAGGAG GAAGAGGAGGAGGAGGAGGAGGAAGAGTGTGAACCCCAGGCAGTGCCAGTGTCTCCGGCC TCAGCTTGCAGCCCCCCGCTGCAGCAGCCACAGGGCTCCCGGGTGCTGGCCACCCTACGT GGCCAGGTGCTCCTGGGCAGGGGCGTGGGTGCTATAGGTGGGCAGTGGTGGCGTCGACGG GCGCAGCTGACCCGGGAGAAGCGCTTCACCTTCGTGCTGGCTGTGGTCATTGGCGTTTTT GTGCTCTGCTGGTTCCCCTTCTTCTTCAGCTACAGCCTGGGAGCCATCTGCCCGAAGCAC TGCAAGGTGCCCCATGGCCTCTTCCAGTTCTTCTTCTGGATCGGCTACTGCAACAGCTCA CTGAACCCTGTTATCTACACCATCTTCAACCAGGACTTCCGCCGTGCCTTCCGGAGGATC CTGTGCCGCCCGTGGACCCAGACGGCCTGGTGA
- Chromosome Location
- 2
- Locus
- 2p13-q13
- External Identifiers
Resource Link UniProtKB ID P18089 UniProtKB Entry Name ADA2B_HUMAN GenBank Protein ID 178198 GenBank Gene ID M34041 GenAtlas ID ADRA2B HGNC ID HGNC:282 - General References
- Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL, Caron MG, Lefkowitz RJ: Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5094-8. [Article]
- Weinshank RL, Zgombick JM, Macchi M, Adham N, Lichtblau H, Branchek TA, Hartig PR: Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor. Mol Pharmacol. 1990 Nov;38(5):681-8. [Article]
- Small KM, Brown KM, Forbes SL, Liggett SB: Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem. 2001 Feb 16;276(7):4917-22. Epub 2000 Oct 30. [Article]
- Cayla C, Heinonen P, Viikari L, Schaak S, Snapir A, Bouloumie A, Karvonen MK, Pesonen U, Scheinin M, Paris H: Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene. Biochem Pharmacol. 2004 Feb 1;67(3):469-78. [Article]
- Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article]
- Chang AC, Ho TF, Chang NC: In vitro amplification by polymerase chain reaction of a partial gene encoding the third subtype of alpha-2 adrenergic receptor in humans. Biochem Biophys Res Commun. 1990 Oct 30;172(2):817-23. [Article]
- Li C, Fan Y, Lan TH, Lambert NA, Wu G: Rab26 modulates the cell surface transport of alpha2-adrenergic receptors from the Golgi. J Biol Chem. 2012 Dec 14;287(51):42784-94. doi: 10.1074/jbc.M112.410936. Epub 2012 Oct 26. [Article]
- De Fusco M, Vago R, Striano P, Di Bonaventura C, Zara F, Mei D, Kim MS, Muallem S, Chen Y, Wang Q, Guerrini R, Casari G: The alpha2B-adrenergic receptor is mutant in cortical myoclonus and epilepsy. Ann Neurol. 2014 Jan;75(1):77-87. doi: 10.1002/ana.24028. Epub 2014 Jan 2. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00800 Fenoldopam approved unknown antagonist Details DB01392 Yohimbine approved, investigational, vet_approved yes antagonist Details DB00484 Brimonidine approved yes agonist Details DB00368 Norepinephrine approved yes agonist Details DB04855 Dronedarone approved yes antagonist Details DB05461 OPC-28326 investigational unknown Details DB05492 Epicept NP-1 investigational unknown Details DB06262 Droxidopa approved, investigational yes agonist Details DB06216 Asenapine approved unknown antagonist Details DB06229 Ocaperidone investigational unknown Details DB00575 Clonidine approved yes agonist Details DB01200 Bromocriptine approved, investigational, withdrawn unknown agonist Details DB00589 Lisuride approved, investigational unknown other/unknown Details DB00248 Cabergoline approved unknown antagonist Details DB00714 Apomorphine approved, investigational unknown agonist Details DB01267 Paliperidone approved unknown antagonist Details DB01224 Quetiapine approved unknown antagonist Details DB00246 Ziprasidone approved unknown antagonist Details DB00363 Clozapine approved no antagonist Details DB01238 Aripiprazole approved, investigational no antagonistligand Details DB01403 Methotrimeprazine approved, investigational unknown antagonist Details DB00292 Etomidate approved yes agonist Details DB00726 Trimipramine approved unknown other/unknown Details DB00925 Phenoxybenzamine approved unknown antagonist Details DB01363 Ephedra sinica root nutraceutical yes agonist Details DB01577 Metamfetamine approved, illicit, withdrawn yes agonist Details DB06694 Xylometazoline approved, investigational yes agonist Details DB00668 Epinephrine approved, vet_approved yes agonist Details DB05271 Rotigotine approved unknown antagonist Details DB00408 Loxapine approved unknown binder Details DB01136 Carvedilol approved, investigational unknown antagonist Details DB00457 Prazosin approved unknown binder Details DB00629 Guanabenz approved, investigational unknown binder Details DB00797 Tolazoline approved, vet_approved unknown binder Details DB00935 Oxymetazoline approved, investigational yes agonist Details DB00964 Apraclonidine approved unknown agonist Details DB01018 Guanfacine approved, investigational unknown binder Details DB06148 Mianserin approved, investigational unknown antagonist Details DB11124 Racepinephrine approved yes agonist Details DB06153 Pizotifen approved unknown antagonist Details DB04846 Celiprolol approved, investigational unknown antagonist Details DB14185 Aripiprazole lauroxil approved, investigational no Details DB00502 Haloperidol approved unknown Details DB00734 Risperidone approved, investigational unknown antagonist Details DB00697 Tizanidine approved, investigational unknown agonist Details DB00217 Bethanidine approved yes agonist Details DB01186 Pergolide approved, investigational, vet_approved, withdrawn unknown agonist Details DB00477 Chlorpromazine approved, investigational, vet_approved unknown inhibitor Details DB00543 Amoxapine approved unknown antagonist Details DB00540 Nortriptyline approved unknown antagonist Details DB00934 Maprotiline approved, investigational unknown antagonist Details DB01151 Desipramine approved, investigational unknown binder Details DB09202 Cirazoline experimental yes antagonist Details DB06678 Esmirtazapine investigational unknown antagonist Details DB06707 Levonordefrin approved yes agonist Details DB13025 Tiapride investigational yes antagonist Details DB09167 Dosulepin approved yes antagonist Details DB09304 Setiptiline experimental unknown antagonist Details DB00397 Phenylpropanolamine approved, vet_approved, withdrawn unknown Details DB09194 Etoperidone withdrawn unknown antagonist Details DB09195 Lorpiprazole approved yes antagonist Details DB11477 Xylazine vet_approved yes agonist Details DB00433 Prochlorperazine approved, vet_approved no antagonist Details DB00715 Paroxetine approved, investigational unknown binder Details DB00193 Tramadol approved, investigational yes inducer Details DB01175 Escitalopram approved unknown inhibitor Details DB06764 Tetryzoline approved unknown agonist Details DB00320 Dihydroergotamine approved, investigational unknown agonist Details DB00692 Phentolamine approved unknown antagonist Details DB01365 Mephentermine approved yes agonist Details DB00182 Amphetamine approved, illicit, investigational unknown agonist Details DB09205 Moxisylyte approved, investigational yes antagonist Details DB09229 Aranidipine experimental unknown agonist Details DB11577 Indigotindisulfonic acid approved, investigational no agonist Details DB13345 Dihydroergocristine approved, experimental yes antagonistagonist Details DB01049 Ergoloid mesylate approved yes antagonistagonist Details DB11273 Dihydroergocornine approved yes antagonistagonist Details DB11278 DL-Methylephedrine approved yes agonist Details DB00268 Ropinirole approved, investigational unknown antagonist Details DB01069 Promethazine approved, investigational unknown antagonist Details DB01576 Dextroamphetamine approved, illicit unknown inhibitorinducer Details